Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra

Go back to Madrigal Pharma (MDGL) option IV into FDA approves Madrigal Pharmaceuticals' Rezdiffra
(NASDAQ: MDGL) Delayed: 509.76 -3.67 (0.71%)
Previous Close $513.43    52 Week High $18.24 
Open $516.83    52 Week Low $6.60 
Day High $527.71    P/E N/A 
Day Low $509.07    EPS $0.00 
Volume 399,806